Efficacy of Intra-arterial Infusion Therapy Using a Combination of Cisplatin and Docetaxel for Recurrent Head and Neck Cancers Compared with Cisplatin Alone
- 1 December 2003
- journal article
- clinical trial
- Published by Elsevier in Clinical Oncology
- Vol. 15 (8) , 467-472
- https://doi.org/10.1016/j.clon.2003.07.003
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Chemotherapy in the management of squamous-cell carcinoma of the head and neckThe Lancet Oncology, 2001
- Concomitant Chemotherapy and Reirradiation as Management for Recurrent Cancer of the Head and NeckAmerican Journal of Clinical Oncology, 1999
- Docetaxel and cisplatin: An active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neckAnnals of Oncology, 1999
- Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neckCancer, 1998
- Surgical management of local and regional recurrent head and neck squamous cell carcinomaCurrent Opinion in Oncology, 1998
- Docetaxel: an active drug for squamous cell carcinoma of the head and neck.Journal of Clinical Oncology, 1996
- Superselective cisplatin (CDDP)-carboplatin (CBDCA) combined infusion for head and neck cancersEuropean Journal of Radiology, 1995
- Superselective intraarterial infusion of cisplatin for squamous cell carcinoma of the mouth: preliminary clinical experience.American Journal of Roentgenology, 1995
- Head and Neck CancerNew England Journal of Medicine, 1993
- Rapid superselective high‐dose cisplatin infusion for advanced head and neck malignanciesHead & Neck, 1992